Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study-Reference-Cited by-同舟云学术

Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study

Published:2010-01-08 Issue:3 Volume:25 Page:368-376
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Rascol Olivier,Azulay Jean-Philippe,Blin Olivier,Bonnet Anne-Marie,Brefel-Courbon Christine,Césaro Pierre,Damier Philippe,Debilly Bérengère,Durif Frank,Galitzky Monique,Grouin Jean-Marie,Pennaforte Sylvie,Villafane Gabriel,Yaici Sadek,Agid Yves

Funder

IRIS, Institut de Recherches Internationales SERVIER, Courbevoie France

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.22922/fullpdf

Reference27 articles.

1. Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004;Goetz;Mov Disord,2005

2. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the quality standards sub-committee of the American Academy of Neurology;Pahwa;Neurology,2006

3. Subcutaneous apomorphine: an evidence based review of its use in Parkinson's disease;Deleu;Drugs Aging,2004

4. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease;Chen;Clin Ther,2005

5. A randomized, double-blind, placebo-controlled trial of subcutaneous injected apomorphine for Parkinsonian OFF events;Dewey;Arch Neurol,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics;Clinical Neurology and Neurosurgery;2024-10

2. Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease;Current Neuropharmacology;2023-05

3. 3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy;Pharmaceutics;2022-04-25

4. Oral Health Disorders in Parkinson’s Disease: More than Meets the Eye;Journal of Parkinson's Disease;2021-10-12

5. NON-ORAL DRUG DELIVERY IN PARKINSON’S DISEASE: CURRENT APPLICATIONS AND FUTURE;Turkish Journal of Pharmaceutical Sciences;2021-06-01